In silico molecular modeling and docking studies on the leishmanial tryparedoxin peroxidase

Leishmaniasis is one of the most common form of neglected parasitic disease that affects about 350 million people worldwide. Leishmanias have a trypanothione mediated hydroperoxide metabolism to eliminate endogenous or exogenous oxidative agents. Both of 2-Cys peroxiredoxin (Prx) and glutathione peroxidase type tryparedoxin peroxidase (Px) are the terminal enzymes in the trypanothione dependent detoxification system. Therefore absence of trypanothione redox system in mammals and the sensitivity of trypanosomatids against oxidative stress, enzymes of this pathway are drug targets candidates. In this study, 3D structure of tryparedoxin peroxidase (2-Cys peroxiredoxin type) from Leishmania donovani (LdTXNPx) was described by homology modeling method based on the template of tryparedoxin peroxidase from Crithidia fasciculata and selected compounds were docked to the active site pocket. The quality of the 3D structure of the model was confirmed by various web based validation programs. When compared secondary and tertiary structure of the model, it showed a typical thioredoxin fold containing a central beta-sheet and three alpha-helices. Docking study showed that the selected compound 2 (CID 16073813) interacted with the active site amino acids and binding energy was -118.675 kcal/mol.

Saved in:
Bibliographic Details
Main Author: Mutlu,Ozal
Format: Digital revista
Language:English
Published: Instituto de Tecnologia do Paraná - Tecpar 2014
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-89132014000200013
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S1516-89132014000200013
record_format ojs
spelling oai:scielo:S1516-891320140002000132014-04-04In silico molecular modeling and docking studies on the leishmanial tryparedoxin peroxidaseMutlu,Ozal Homology modeling docking Leishmania donovani tryparedoxin peroxidase hydroperoxide metabolism Leishmaniasis is one of the most common form of neglected parasitic disease that affects about 350 million people worldwide. Leishmanias have a trypanothione mediated hydroperoxide metabolism to eliminate endogenous or exogenous oxidative agents. Both of 2-Cys peroxiredoxin (Prx) and glutathione peroxidase type tryparedoxin peroxidase (Px) are the terminal enzymes in the trypanothione dependent detoxification system. Therefore absence of trypanothione redox system in mammals and the sensitivity of trypanosomatids against oxidative stress, enzymes of this pathway are drug targets candidates. In this study, 3D structure of tryparedoxin peroxidase (2-Cys peroxiredoxin type) from Leishmania donovani (LdTXNPx) was described by homology modeling method based on the template of tryparedoxin peroxidase from Crithidia fasciculata and selected compounds were docked to the active site pocket. The quality of the 3D structure of the model was confirmed by various web based validation programs. When compared secondary and tertiary structure of the model, it showed a typical thioredoxin fold containing a central beta-sheet and three alpha-helices. Docking study showed that the selected compound 2 (CID 16073813) interacted with the active site amino acids and binding energy was -118.675 kcal/mol.info:eu-repo/semantics/openAccessInstituto de Tecnologia do Paraná - TecparBrazilian Archives of Biology and Technology v.57 n.2 20142014-04-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-89132014000200013en10.1590/S1516-89132014000200013
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Mutlu,Ozal
spellingShingle Mutlu,Ozal
In silico molecular modeling and docking studies on the leishmanial tryparedoxin peroxidase
author_facet Mutlu,Ozal
author_sort Mutlu,Ozal
title In silico molecular modeling and docking studies on the leishmanial tryparedoxin peroxidase
title_short In silico molecular modeling and docking studies on the leishmanial tryparedoxin peroxidase
title_full In silico molecular modeling and docking studies on the leishmanial tryparedoxin peroxidase
title_fullStr In silico molecular modeling and docking studies on the leishmanial tryparedoxin peroxidase
title_full_unstemmed In silico molecular modeling and docking studies on the leishmanial tryparedoxin peroxidase
title_sort in silico molecular modeling and docking studies on the leishmanial tryparedoxin peroxidase
description Leishmaniasis is one of the most common form of neglected parasitic disease that affects about 350 million people worldwide. Leishmanias have a trypanothione mediated hydroperoxide metabolism to eliminate endogenous or exogenous oxidative agents. Both of 2-Cys peroxiredoxin (Prx) and glutathione peroxidase type tryparedoxin peroxidase (Px) are the terminal enzymes in the trypanothione dependent detoxification system. Therefore absence of trypanothione redox system in mammals and the sensitivity of trypanosomatids against oxidative stress, enzymes of this pathway are drug targets candidates. In this study, 3D structure of tryparedoxin peroxidase (2-Cys peroxiredoxin type) from Leishmania donovani (LdTXNPx) was described by homology modeling method based on the template of tryparedoxin peroxidase from Crithidia fasciculata and selected compounds were docked to the active site pocket. The quality of the 3D structure of the model was confirmed by various web based validation programs. When compared secondary and tertiary structure of the model, it showed a typical thioredoxin fold containing a central beta-sheet and three alpha-helices. Docking study showed that the selected compound 2 (CID 16073813) interacted with the active site amino acids and binding energy was -118.675 kcal/mol.
publisher Instituto de Tecnologia do Paraná - Tecpar
publishDate 2014
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-89132014000200013
work_keys_str_mv AT mutluozal insilicomolecularmodelinganddockingstudiesontheleishmanialtryparedoxinperoxidase
_version_ 1756423909778915328